Compatibility and osmolality of inhaled N-acetylcysteine nebulizing solution with fenoterol and ipratropium

Am J Health Syst Pharm. 2005 Apr 15;62(8):828-33. doi: 10.1093/ajhp/62.8.828.

Abstract

Purpose: The compatibility, pH, and osmolality of N-acetylcysteine (NAC) nebulizing solution in the presence of ipratropium bromide or fenoterol hydrobromide were studied.

Methods: Portions (400 microL) of each mixture were sampled immediately upon mixing and one, two, three, four, five, six, and seven hours after mixing and assayed by high-performance liquid chromatography. Osmolality was measured by sampling 100 microL from the filling cup at a five-minute interval during nebulization and by the freezing-point-depression method.

Results: Adding NAC solution to fenoterol solution raised the pH from 3.20 to 7.90 and the osmolality to a mean +/- S.D. of 1400.67 +/- 4.51 mOsm/kg. Fenoterol concentrations decreased to 93.71% and NAC concentrations to 92.54% of initial concentrations after seven hours. Mixing ipratropium with NAC solution raised the pH from 3.74 to 7.95 and the osmolality to a mean +/- S.D. of 1413 +/- 11.79 mOsm/kg. The initial ipratropium concentration declined 7.39% and 10.91% one and two hours after mixing with NAC solution, respectively.

Conclusion: NAC and ipratropium were stable in nebulizing solution within one hour of mixing. NAC and fenoterol were compatible for at least seven hours.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcysteine / administration & dosage*
  • Administration, Inhalation
  • Adrenergic beta-Agonists / administration & dosage*
  • Bronchodilator Agents / administration & dosage*
  • Fenoterol / administration & dosage*
  • Hydrogen-Ion Concentration
  • Ipratropium / administration & dosage*
  • Mass Spectrometry
  • Nebulizers and Vaporizers
  • Osmolar Concentration
  • Oxidation-Reduction
  • Solutions / standards*

Substances

  • Adrenergic beta-Agonists
  • Bronchodilator Agents
  • Solutions
  • Fenoterol
  • Ipratropium
  • Acetylcysteine